Precision Health Clinical Trials

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

Conditions:   Carcinoma, Squamous Cell;   Head and Neck Neoplasms;   Oropharyngeal Neoplasms
Interventions:   Radiation: Intensity Modulated Radiotherapy (IMRT) - deintensified;   Radiation: Intensity Modulated Radiotherapy (IMRT) - standard;   Drug: Cisplatin (or alternative) - deintensified;   Drug: Cisplatin (or alternative) - standard;   Procedure: Assessment for surgical evaluation
Sponsor:   UNC Lineberger Comprehensive Cancer Center
Recruiting

Genetics of Ehlers-Danlos Syndrome

Conditions:   Genetics Syndrome;   Ehlers-Danlos Syndrome
Intervention:   Diagnostic Test: Genotyping
Sponsor:   Boston University
Recruiting

Composition and Collection Feasibility of Gut Microbiota in Children With and Without Obesity

Condition:   Childhood Obesity
Intervention:  
Sponsor:   University of Illinois College of Medicine at Peoria
Recruiting

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

Conditions:   Lymphoma, Non-Hodgkin;   Lymphoma, Hodgkin
Intervention:   Drug: Chemotherapy
Sponsors:   Samsung Medical Center;   Samsung Genomic Institute
Recruiting

Genetics of Differences of Sex Development and Hypospadias

Conditions:   Disorders of Sex Development;   Hypospadias
Intervention:   Genetic: Return of Genetic Results
Sponsor:   Boston Children's Hospital
Recruiting

Chilean Gastric Cancer Task Force (FORCE 1)

Condition:   Biomarkers
Intervention:  
Sponsors:   Pontificia Universidad Catolica de Chile;   Center of Excellence of Precision Medicine (CEMP);   Advanced Center for Chronic Diseases (ACCDiS);   Millennium Institute on Immunology and Immunotherapy;   Center UC for Investigation in Oncology (CITO);   Centre of Clinical Research, Health Technology Assessment Unit;   National Scientific and Technical Research Council (CONICET), Argentina;   Grupo Oncologico Cooperativo del Sur (GOCS), Argentina;   Hospital Universitario central de Asurias, Oviedo, España;   Hospital Morales Meseger, Murcia, España;   Centro de Cancer. Pontificia Universidad Católica de Chile;   Hematology and Oncology Department
Recruiting

Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)

Condition:   Autoimmune Diseases
Intervention:   Drug: Hydroxychloroquine Oral Tablet
Sponsor:   Assiut University
Not yet recruiting

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Condition:   Malignant Peripheral Nerve Sheath Tumors
Intervention:  
Sponsors:   Washington University School of Medicine;   Boston's Children Hospital
Recruiting

Profiling of Oncology Patients as Part of Clinical Care and Research

Condition:   Gynecologic Cancer
Intervention:  
Sponsor:   University of Auckland, New Zealand
Recruiting

Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol

Condition:   Endometriosis
Intervention:  
Sponsors:   Yale University;   Augusta University;   Penn State University;   University of California, San Francisco;   University of North Carolina;   University of Oklahoma;   University of Pennsylvania;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Pages